Functional Interactions between Cancer Cells and Sensory Neurons

癌细胞和感觉神经元之间的功能相互作用

• 批准号: 8011521
• 负责人: Donald Simone
• 金额: $ 5.38万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-01-01 至 2012-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8011521
• 关键词: Absence of pain sensation; Accounting; Adenosine; Adult; Adverse effects; Afferent Neurons; Agonist; Analgesics; Behavioral; Bone remodeling; Calcium Signaling; Cancer Model; Cancer Pain Management; Cells; Child; Coculture Techniques; Collaborations; Development; Diagnosis; Dose; Effectiveness; Electrophysiology (science); Fiber; Grant; Hyperalgesia; In Vitro; Inflammation; Inflammatory; Inflammatory Response; Institutes; Lead; Ligands; Malignant Bone Neoplasm; Malignant Neoplasms; Mechanics; Methods; Modeling; Morphine; Mus; National Cancer Institute; Neoplasm Metastasis; Nerve Degeneration; Nerve Endings; Neuraxis; Neurons; Neuropathy; Nociception; Nociceptors; Opioid; Opioid Receptor; P2X-receptor; Pain; Pain management; Patients; Peripheral; Physiology; Public Health; Quality of life; Relative (related person); Reporting; Research; Resistance; Sensory; Signal Transduction; Spinal Cord; Spinal Ganglia; TRPV1 gene; Therapeutic; Therapeutic Uses; Ukraine; United States; United States National Institutes of Health; World Health Organization; bone; cancer cell; cancer pain; chronic pain; experience; fibrosarcoma; improved; in vitro Model; in vivo; injured; neuronal excitability; novel; novel strategies; patch clamp; public health relevance; receptor; receptor function; release factor; response; tripolyphosphate; tumor; tumor growth

DESCRIPTION (provided by applicant): Pain from cancer, particularly cancer that metastasizes to bone, is often severe, difficult to manage, and contributes significantly to the patients' poor quality of life. Although opioids remain the primary treatment for managing severe cancer pain, the relative resistance of cancer pain to opioids requires increased doses, which limit their use because of the many undesirable side effects associated with actions in the central nervous system. It is important to understand the mechanisms by which opioids become less effective in treating cancer pain. The mechanisms that drive cancer pain are multi-factorial and include bone remodeling, inflammatory responses, neurodegeneration, and release of algesic substances from the cancer cells that excite or sensitize nociceptors on primary afferent fibers. ATP is one of the known algesic substances that cancer cells contain and release during tumor growth. ATP activates peripheral P2X receptors which are located on nociceptive nerve endings. Previous behavioral studies from our group indicated that ATP contributes to the development of hyperalgesia in a murine model of bone cancer. Moreover, opioids modulate signaling at P2X receptors. Opioids such as morphine decrease ATP-evoked currents that occur through P2X receptors. We hypothesize that this opioid modulation of signaling through the P2X receptor is diminished by cancer cells, and that this may contribute to the decreased effect of opioids in cancer pain. In the proposed project, we will use an in vivo and a new in vitro co-culture method to determine the effect of cancer cells on ATP-evoked responses of dorsal root ganglion (DRG) neurons, how those responses are modulated by 5- and 4-opioid receptor agonists, and whether cancer cells promote a change in the expression of opioid receptors in DRG neurons. We will determine the effect of fibrosarcoma cells on P2X- dependent activation of mouse DRG neurons, changes in opioid modulation of P2X currents produced by cancer cells, and alterations in expression of 5- and 4-opioid receptors. Also, we will compare changes that occur in vivo (in tumor-bearing mice) to changes that occur in our co-culture model in vitro. The proposed studies will be done in Ukraine (Kiev) at the Bogomoletz Institute of Physiology in collaboration with Dr. Oleg A. Krishtal, who is an expert in patch clamp electrophysiology and P2X receptor function. This study is an extension of our ongoing project, NIH Grant CA091007, in which we are examining the contribution of peripheral P2X and TRPV1 receptors in cancer pain and nociceptor sensitization Results from these studies will provide new information on the mechanisms by which ATP contributes to cancer pain, and how opioids modulate ATP-evoked responses during tumor growth. Understanding how opioids can modulate cancer-related changes in responses of sensory neurons may lead to the development of novel approaches for managing cancer pain. PUBLIC HEALTH RELEVANCE: It is estimated by the National Cancer Institute that more than 1.4 million new cases of cancer were diagnosed in the United States in 2007, and the World Health Organization estimates that up to 15 million new cases of cancer may be diagnosed world-wide in 2020. Approximately 85% of adult patients with terminal cancer report intolerable pain and up to 75% of children with cancer experience pain. Understanding the mechanisms that drive cancer pain so that new and improved therapeutic approaches for pain management can be developed is a relevant public health issue.

描述（由申请人提供）：癌症的疼痛，尤其是转移到骨骼的癌症，通常很严重，难以管理，并且对患者的生活质量差产​​生了重大贡献。尽管阿片类药物仍然是管理严重癌症疼痛的主要治疗方法，但癌症疼痛对阿片类药物的相对抵抗需要增加剂量，这限制了它们的使用，因为与中枢神经系统中的作用相关的许多不良副作用。重要的是要了解阿片类药物在治疗癌症疼痛方面的有效性降低的机制。 驱动癌症疼痛的机制是多因素的，包括骨骼重塑，炎症反应，神经变性以及从癌细胞中释放algeic物质，这些癌细胞激发或敏感了对初级传入纤维上的伤害感受器。 ATP是癌细胞在肿瘤生长过程中含有和释放的已知符号物质之一。 ATP激活位于伤害性神经末端的外周P2X受体。我们小组的先前行为研究表明，ATP有助于在骨癌的鼠模型中发展痛觉过敏。此外，阿片类药物在P2X受体处调节信号传导。阿片类药物（例如吗啡）降低了通过P2X受体发生的ATP诱发电流。我们假设癌细胞通过P2X受体进行信号传导的这种阿片类药物调节，这可能有助于阿片类药物在癌症疼痛中的影响下降。 在拟议的项目中，我们将使用一种体内和一种新的体外共培养方法来确定癌细胞对ATP诱发的背根神经元（DRG）神经元的影响，这些反应如何受到5和4-阿片类药物受体激动剂的调节，以及癌细胞在DRGNeurons中的表达中是否促进了癌细胞的变化。我们将确定纤维肉瘤细胞对小鼠DRG神经元的P2X依赖性激活的影响，癌细胞产生的P2X电流的阿片类药物调节变化以及5-阿片受体和4-阿片受体的表达改变。同样，我们将比较体内（肿瘤小鼠中）发生的变化与我们在体外共培养模型中发生的变化。 拟议的研究将与Bogomoletz生理研究所的乌克兰（基辅）与Oleg A. Krishtal博士合作，后者是斑块夹电物质生理学和P2X受体功能的专家。这项研究是我们正在进行的项目NIH Grant CA091007的延伸，在其中我们正在研究周围P2X和TRPV1受体在癌症疼痛中的贡献，这些研究的伤害感受器的敏感性将提供有关ATP对癌症贡献的机制的新信息，以及如何对癌症进行贡献，以及Apeio atp-ev-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef-ef tumor exce thumor thumor thumor thumor thumor thumor thumor thumor thumor的研究。了解阿片类药物如何调节癌症相关的感觉神经元反应的变化可能会导致用于管理癌症疼痛的新方法的发展。 公共卫生相关性：由国家癌症研究所估计，2007年在美国诊断出140万例新病例，世界卫生组织估计，2020年全球可能会诊断出多达1500万例新的癌症病例。大约85％的成年患者大约有85％的患有无法忍受的成年患者报告了无法忍受的疼痛，并且在患有癌症患有癌症的儿童中最多可以疼痛75％。了解驱动癌症疼痛的机制，以便可以开发出新的和改进的治疗方法来开发疼痛管理的方法是一个相关的公共卫生问题。